Cargando…

Innovative Care for Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Use of Bedside Intestinal Ultrasound to Optimize Management

BACKGROUND: The COVID-19 pandemic caused by SARS-CoV-2 has reduced access to endoscopy and imaging. Safe alternatives, available at the bedside, are needed for accurate, non-invasive strategies to evaluate disease activity. The aim of this study is to establish the impact of clinic-based bedside int...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Cathy, Ma, Christopher, Ingram, Richard J M, Chan, Melissa, Kheirkhahrahimabadi, Hengameh, Martin, Marie-Louise, Seow, Cynthia H, Kaplan, Gilaad G, Heatherington, Joan, Devlin, Shane M, Panaccione, Remo, Novak, Kerri L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992330/ https://www.ncbi.nlm.nih.gov/pubmed/36785574 http://dx.doi.org/10.1093/jcag/gwac006

Ejemplares similares

A173 INNOVATIVE CARE FOR INFLAMMATORY BOWEL DISEASE PATIENTS DURING THE COVID-19 PANDEMIC: USE OF BEDSIDE INTESTINAL ULTRASOUND TO OPTIMIZE MANAGEMENT
por: Novak, K L, et al.
Publicado: (2021)

Bedside Intestinal Ultrasound Performed in an Inflammatory Bowel Disease Urgent Assessment Clinic Improves Clinical Decision-Making and Resource Utilization
por: St-Pierre, Joëlle, et al.
Publicado: (2023)

The Role of Bowel Ultrasound in Detecting Subclinical Inflammation in Pregnant Women with Crohn’s Disease
por: Leung, Yvette, et al.
Publicado: (2019)

The Argument Against a Biosimilar Switch Policy for Infliximab in Patients with Inflammatory Bowel Disease Living in Alberta
por: Kaplan, Gilaad G, et al.
Publicado: (2020)

Point of Care Ultrasound Accurately Distinguishes Inflammatory from Noninflammatory Disease in Patients Presenting with Abdominal Pain and Diarrhea
por: Novak, Kerri L., et al.
Publicado: (2016)

Differential Effect of Genetic Burden on Disease Phenotypes in Crohn’s Disease and Ulcerative Colitis in a Canadian Cohort
por: Pang, Jack X Q, et al.
Publicado: (2020)

Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration
por: Kuenzig, M. Ellen, et al.
Publicado: (2016)

Nutritional interventions in adult fibrostenotic Crohn’s disease: A systematic review
por: Cooper, Jared L., et al.
Publicado: (2023)

A192 EFFICACY OF USTEKINUMAB IN SMALL BOWEL STRICTURES OF FIBROSTENOTIC CROHN'S DISEASE AS ASSESSED BY INTESTINAL ULTRASOUND
por: St-Pierre, J, et al.
Publicado: (2023)

SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
por: Quan, Joshua, et al.
Publicado: (2022)

Surgical Rates for Crohn’s Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study
por: Ma, Christopher, et al.
Publicado: (2017)

A97 DEVELOPMENT OF PREDICTION MODELS FOR THE TRIAGING OF REFERRALS OF INDIVIDUALS WITH SUSPECTED INFLAMMATORY BOWEL DISEASE TO IMPROVE PROMPT ACCESS TO CARE
por: St-Pierre, J, et al.
Publicado: (2022)

Preoperative Ustekinumab Treatment Is Not Associated With Increased Postoperative Complications in Crohn’s Disease: A Canadian Multi-Centre Observational Cohort Study
por: Shim, Hang Hock, et al.
Publicado: (2018)

Insights into the role of cannabis in the management of inflammatory bowel disease
por: Picardo, Sherman, et al.
Publicado: (2019)

Su1484: SEROLOGICAL RESPONSES TO SARS-COV-2 VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A PROSPECTIVE COHORT STUDY
por: Quan, Joshua, et al.
Publicado: (2022)

The Inflammatory Bowel Diseases and Ambient Air Pollution: A Novel Association
por: Kaplan, Gilaad G, et al.
Publicado: (2010)

654: A THIRD DOSE OF SARS-COV-2 VACCINE YIELDS HIGH ANTIBODY LEVELS COMPARED TO TWO DOSE VACCINATION SCHEDULE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Quan, Joshua, et al.
Publicado: (2022)

Patient preferences for maintenance therapy in Crohn’s disease: A discrete-choice experiment
por: Hazlewood, Glen S., et al.
Publicado: (2020)

Complementary and alternative medications in the management of inflammatory bowel disease
por: Picardo, Sherman, et al.
Publicado: (2020)

Quantitative Metabolomic Profiling of Serum, Plasma, and Urine by (1)H NMR Spectroscopy Discriminates between Patients with Inflammatory Bowel Disease and Healthy Individuals
por: Schicho, Rudolf, et al.
Publicado: (2012)

Fr099 HEALTHCARE PROVIDER SATISFACTION WITH VIRTUAL CARE DELIVERY IN ALBERTA DURING THE COVID-19 PANDEMIC.
por: Olayinka, Lily, et al.
Publicado: (2021)

Relevance of monitoring transmural disease activity in patients with Crohn’s disease: current status and future perspectives
por: Wilkens, Rune, et al.
Publicado: (2021)

Fr098 IMPACT OF COVID-19 PANDEMIC IN IBD PATIENT CARE
por: Dahiya, Monica, et al.
Publicado: (2021)

Declining Corticosteroid Use for Inflammatory Bowel Disease Across Alberta: A Population-Based Cohort Study
por: Seow, Cynthia H, et al.
Publicado: (2022)

The Impact of the COVID-19 Pandemic on IBD Care in Alberta: Patient and Provider Perspectives
por: Dahiya, Monica, et al.
Publicado: (2022)

The Association of Smoking and Surgery in Inflammatory Bowel Disease is Modified by Age at Diagnosis
por: Frolkis, Alexandra D, et al.
Publicado: (2016)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines—Biology, Current Evidence and Recommendations
por: Murthy, Sanjay K, et al.
Publicado: (2021)

Surgery for Inflammatory Bowel Disease Has Unclear Impact on Female Fertility: A Cochrane Collaboration Systematic Review
por: Lee, Sangmin, et al.
Publicado: (2020)

Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2023)

Intestinal Ultrasound for the Pediatric Gastroenterologist: A Guide for Inflammatory Bowel Disease Monitoring in Children: Expert Consensus on Behalf of the International Bowel Ultrasound Group (IBUS) Pediatric Committee
por: Kellar, Amelia, et al.
Publicado: (2022)

Patterns and predictors of long-term retention of inflammatory bowel or rheumatoid disease patients on innovator infliximab: an analysis of a Canadian prescriptions claims database
por: Baer, Philip A, et al.
Publicado: (2018)

The four epidemiological stages in the global evolution of inflammatory bowel disease
por: Kaplan, Gilaad G., et al.
Publicado: (2020)

Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: A large population-based study
por: Quaresma, Abel B., et al.
Publicado: (2022)

Serological responses to the first four doses of SARS-CoV-2 vaccine in patients with inflammatory bowel disease
por: Quan, Joshua, et al.
Publicado: (2022)

Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study
por: Kaplan, Gilaad G, et al.
Publicado: (2022)

Cost-Effectiveness of Tight Control for Crohn’s Disease With Adalimumab-Based Treatment: Economic Evaluation of the CALM Trial From a Canadian Perspective
por: Lakatos, Peter L, et al.
Publicado: (2022)

Nutrition Center of Excellence (COE) in Inflammatory Bowel Disease—A Model and Rationale for Development
por: Shommu, Nusrat S, et al.
Publicado: (2019)

The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007 fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study
por: Kuenzig, M. Ellen, et al.
Publicado: (2017)

Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Risk Factors and Medications
por: Targownik, Laura E, et al.
Publicado: (2021)

Adverse Events and Serological Responses After SARS-CoV-2 Vaccination in Individuals With Inflammatory Bowel Disease
por: Markovinović, Ante, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_91b2umoj3hb51dr48dir75g83f